UW-Madison recently received the official notice from the NIH National Center for Advancing Translational Sciences (NCATS) of a $41,549,200 Clinical and Translational Science Award (CTSA) leading to its renewal for 2012-2017. The CTSA funds the UW-ICTR, a partnership between the UW Schools of Medicine and Public Health, Pharmacy, Nursing, Veterinary Medicine, and the College of Engineering, plus its Marshfield Clinical partner.
One aspect of the new ICTR mission is to focus on filling a gap in resources on campus for the development of new therapeutics (drugs and devices) for any clinical indications. To this end, this RFI solicits information on specific resources (ie. financial, technical, instrumental, project management etc.) that are needed in anticipation of a new funding opportunity that will be made available through ICTR later in the Fall 2012 to help meet these needs and to support the building of necessary infrastructures.
This RFI invites input from the UW scientific community, potential industry partners, and other members of the public on all aspects of the drug development pathway.
For additional information and response instructions, download the full RFI: http://www.cals.wisc.edu/Research/DrugDiscoveryRFI-8-31-12.pdf
This entry was posted in Funding Opportunities, Research by chillmer. Bookmark the permalink.